Cite
HARVARD Citation
Perera, V. et al. (n.d.). First‐in‐human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS‐962212, a direct, reversible, small molecule factor XIa inhibitor in non‐Japanese and Japanese healthy subjects. British journal of clinical pharmacology. pp. 876-887. [Online].